Study: Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis
Antibodies against tumour necrosis factor-alpha (anti-TNF) are effective therapies in the treatment of ulcerative colitis (UC), but their comparative efficacy is unknown.
This study demonstrates that, compared to placebo, infliximab aka Remicade, adalimumab aka Humira and golimumab aka Simponi are all effective for the induction and maintenance of remission in ulcerative colitis. However, network meta-analysis demonstrates that no single agent is clinically superior to the others and therefore, other factors such as cost, safety, route of administration and patient preference should dictate our choice of anti-TNF agents. http://onlinelibrary.wiley.com/doi/10.1111/apt.12644/pdf
John, Moderator uc
Rx: Remicade 5mg per kg, every 8 weeks
Daily 75mg 6MP + 5g Lialda + Rowasa
Diet: Diet mods and supplements haven't done a thing for me